Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes.
Antoine ChristiaensBenoit BolandMarie GermanidisOlivia DalleurSéverine HenrardPublished in: BMC geriatrics (2020)
GLT overtreatment was present in more than half of these geriatric patients. Many of them were in poor health status and died within one-year. Special attention should be paid to individualisation of the HbA1c goals in the geriatric patients with diabetes, and to GLT de-intensification in those being over-treated.
Keyphrases
- end stage renal disease
- newly diagnosed
- hip fracture
- chronic kidney disease
- ejection fraction
- prognostic factors
- peritoneal dialysis
- working memory
- type diabetes
- risk factors
- public health
- stem cells
- cardiovascular disease
- blood glucose
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- mesenchymal stem cells
- weight loss
- global health
- patient reported